Skip to content
OpenCapital
Get started

Globus Medical GMED Gross unrealized gains, short-term

Other financials

Income statement

See full
Revenue$759.9M+27.0%
Gross profit$525.8M+30.6%
Operating income$150.4M+55.0%
Net income$124.3M+64.7%
EPS (diluted)$0.90+66.7%

Balance sheet

See full
Cash & equivalents$561.0M+21.6%
Total debt$116.3M+25.0%
Total equity$4.7B+15.8%
Total assets$5.4B+15.5%

Cash flow

See full
Operating cash flow$202.4M+14.1%
CapEx$39.6M+9.7%
Free cash flow$162.7M+15.3%

Valuation

See full
Market cap$10.76B+15.7%
Enterprise value$10.31B+15.6%
P/E18.3×-31.7×
P/S3.5×-0.2×

Profitability

See full
Gross margin67.9%+7.3pp
Operating margin17.2%+7.0pp
Net margin18.9%+11.5pp
FCF margin19.7%-1.1pp

Returns & leverage

See full
Return on equity13.3%+8.7pp
Debt / equity0×0.0×
Current ratio4.6×+0.1×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept gmed:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax.

The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Globus Medical's gross unrealized gains, short-term.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Globus Medical's gross unrealized gains, short-term?
Globus Medical (GMED) reported gross unrealized gains, short-term of $2K in Q1 2026.
What is the long-term trend for Globus Medical's gross unrealized gains, short-term?
Over 3 years (2021 to 2025), Globus Medical's gross unrealized gains, short-term has grown at a -68.2% compound annual growth rate (CAGR), from $593K to $19K.